Literature DB >> 30414597

Underdosing of Surfactant for Preterm Babies with Respiratory Distress Syndrome in Clinical Practice: A Retrospective Cohort Study.

Hector Boix1, Segundo Rite2, Luis Arruza3, Cristina Fernandez1, Itziar Serrano2, Irene Baquedano2, Ana Sanchez4, Erika Ferreira4, Patricia Fernandez3, Rosa Gonzalez3, M Dolores Elorza4.   

Abstract

OBJECTIVE: To evaluate the initial doses of surfactant administered to preterm infants with respiratory distress syndrome. STUDY
DESIGN: This is a retrospective cohort study of 206 preterm infants admitted in four level III neonatal intensive care units of acute tertiary care hospitals in Spain between 2013 and 2015.
RESULTS: The mean initial dose of surfactant was 173.9 (37.3) mg/kg, and 47.5% of infants received a dose of 200 mg/kg ± 10% (180-220 mg/kg), 47% less than 180 mg/kg (-10%), and 5.4% more than 220 mg/kg (+10%). Very preterm infants (<28 weeks) received higher initial doses than more mature infants, but in all cases, the mean doses were below the recommended 200 mg/kg (by 9.2% in gestational age 23-28 weeks, by 15.9% in 29-32 weeks, and by 24.3% in >32 weeks).
CONCLUSION: Administration of surfactant below the prescribed dose is a frequent error in clinical practice. Inadvertently rounding down doses seems a plausible explanation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30414597     DOI: 10.1055/s-0038-1675645

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  5 in total

1.  Association of Adherence to Surfactant Best Practice Uses With Clinical Outcomes Among Neonates in Sweden.

Authors:  Pontus Challis; Per Nydert; Stellan Håkansson; Mikael Norman
Journal:  JAMA Netw Open       Date:  2021-05-03

2.  Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies.

Authors:  Barbara Królak-Olejnik; Roman Hożejowski; Tomasz Szczapa
Journal:  Front Pediatr       Date:  2020-11-24       Impact factor: 3.418

3.  Incidence, predictors of success and outcome of LISA in very preterm infants.

Authors:  Gergely Balazs; Andras Balajthy; Magdolna Riszter; Tamas Kovacs; Tamas Szabo; Gusztav Belteki; Gyorgy Balla
Journal:  Pediatr Pulmonol       Date:  2022-04-26

4.  Breath-Triggered Drug Release System for Preterm Neonates.

Authors:  Felix C Wiegandt; Ulrich P Froriep; Fabian Müller; Theodor Doll; Andreas Dietzel; Gerhard Pohlmann
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

5.  RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES.

Authors:  Walusa Assad Gonçalves Ferri; Adriana Carnevale da Silva; Eliana Motta Fernandes Sacramento; Cristina Calixto; Davi Casale Aragon; Jamil Pedro de Siqueira Caldas
Journal:  Rev Paul Pediatr       Date:  2020-11-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.